Results 191 to 200 of about 10,846,120 (403)
Binding of digitoxin and some related cardenolides to human plasma proteins [PDF]
Daniel S. Lukas, Anthony G. De Martino
openalex +1 more source
DeepSite: protein‐binding site predictor using 3D‐convolutional neural networks
J. Jiménez +4 more
semanticscholar +1 more source
Analysis of treatment‐naïve high‐grade serous ovarian carcinoma (HGSOC) and control tissues for ERVs, LINE‐1 (L1), inflammation, and immune checkpoints identified five clusters with diverse patient recurrence‐free survivals. An inflammation score was calculated and correlated with retroelement expression, where one novel cluster (Triple‐I) with high ...
Laura Glossner +6 more
wiley +1 more source
TRANSCORTIN: A CORTICOSTEROID-BINDING PROTEIN OF PLASMA. III. THE EFFECTS OF VARIOUS STEROIDS *† [PDF]
Avery A. Sandberg +2 more
openalex +1 more source
Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor
J. Lan +10 more
semanticscholar +1 more source
Cotargeting EGFR and STAT3 with Erlotinib and TTI‐101 impairs both 2D and 3D growth of ETV1‐overexpressing prostate cancer cells by disrupting a self‐sustaining ETV1–EGFR positive feedback loop that promotes EGFR and STAT3 expression and phosphorylation (activation).
Elsa Gomes Paiva +5 more
wiley +1 more source
Measurement of the Amounts of the Individual Vitamin B12 Binding Proteins in Plasma [PDF]
Charles A. Hall, Alexander E. Finkler
openalex +1 more source
Human cytomegalovirus infection is common in normal prostate epithelium, prostate tumor tissue, and prostate cancer cell lines. CMV promotes cell survival, proliferation, and androgen receptor signaling. Anti‐CMV pharmaceutical compounds in clinical use inhibited cell expansion in prostate cancer models in vitro and in vivo, motivating investigation ...
Johanna Classon +13 more
wiley +1 more source
PROTEIN BINDING OF AZO DYES BY TISSUE HOMOGENATES
Alexander M. Rutenburg +1 more
openalex +1 more source
In luminal (ER+) breast carcinoma (BC), miRNA profiling identified miR‐195‐5p as a key regulator of proliferation that targets CHEK1, CDC25A, and CCNE1. High CHEK1 expression correlates with worse relapse‐free survival after chemotherapy, especially in patients with luminal A subtype.
Veronika Boušková +14 more
wiley +1 more source

